Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Eur J Obstet Gynecol Reprod Biol ; 260: 189-197, 2021 May.
Article in English | MEDLINE | ID: mdl-33838556

ABSTRACT

OBJECTIVE: Hyperandrogenism in females leads to multiple endocrine and metabolic disorders including polycystic ovary syndrome (PCOS) that yields adverse health outcomes across all ages. We sought to estimate the prevalence of hyperandrogenemia and at-risk hyperandrogenism among the US females of different age groups, racial/ethnic, and metabolic characteristics. MATERIALS AND METHODS: A retrospective population-based cross-sectional study of females 6 years or older having serum testosterone measures using the National Health and Nutrition Examination Surveys, 2013-2016 was conducted. Age-appropriate thresholds as per assay methods were used for evaluating high total testosterone, low sex hormone binding globulin (SHBG), and high free androgen index (FAI) levels. The weighted analysis was performed to estimate prevalence and 95 % confidence interval (CI). RESULTS: The prevalence of at-risk hyperandrogenism was estimated as 19.8 % (95 %CI: 18.6 %, 21.2 %) in the overall sample, 11.8 % (95 %CI: 9.5 %, 14.5 %) in prepubertal, 20.5 % (95 %CI: 18.9 %, 22.2 %) in premenopausal, and 21.1 % (95 %CI: 18.7 %-23.7 %) in postmenopausal females with considerable heterogeneity by racial/ethnic and metabolic characteristics. In the entire sample, hyperandrogenemia was estimated as 10.4 % and 4.3 % using total testosterone and FAI respectively while 10.7 % cases had a low SHBG. CONCLUSIONS: At-risk hyperandrogenism is equally prevalent in premenopausal and postmenopausal women with a considerable amount in prepubertal females and varied by racial/ethnic groups depending on specific ages. Regular screening of hyperandrogenism using SHBG and total testosterone measures among at-risk subjects for specific ages is critical for treating and preventing adverse consequences of abnormal hormonal parameters.


Subject(s)
Hyperandrogenism , Polycystic Ovary Syndrome , Androgens , Body Mass Index , Cross-Sectional Studies , Ethnicity , Female , Humans , Hyperandrogenism/epidemiology , Nutrition Surveys , Polycystic Ovary Syndrome/complications , Polycystic Ovary Syndrome/epidemiology , Prevalence , Retrospective Studies , Sex Hormone-Binding Globulin , Testosterone , United States/epidemiology
2.
BMC Pregnancy Childbirth ; 21(1): 247, 2021 Mar 24.
Article in English | MEDLINE | ID: mdl-33761892

ABSTRACT

BACKGROUND: Coronavirus disease (COVID-19) has been associated with adverse pregnancy outcomes. Due to the lack of effective treatments for COVID-19, it becomes imperative to assess the geographical differences and trends in the current clinical care and outcomes of COVID-19 in pregnant women. METHODS: A PubMed search was performed to screen articles reporting therapeutics and outcomes of confirmed COVID-19 in pregnant women prior to August 27, 2020. We performed searches, quality assessments of eligible studies, extracted and reported data according to PRISMA guidelines. Meta-analyses and cumulative meta-analyses of proportions were performed for estimating each outcome and their pattern over time respectively. RESULTS: One thousand two hundred thirty nine pregnant women with COVID-19 from 66 studies were analyzed. In case series analysis reflecting average-risk patients, the proportion of oxygen support, antibiotics, antivirals, and plasma therapy administration except for hydroxychloroquine was substantially higher in Asian studies (55, 78, 80, 6, and 0%) compared to the US (7, 1, 12, 0, and 7%) or European (33, 12, 14, 1, and 26%) studies, respectively. The highest preterm birth and the average length of hospital stay (35%, 11.9 days) were estimated in Asian studies compared to the US studies (13%, 9.4 days) and European studies (29%, 7.3 days), respectively. Even in case reports reflecting severe cases, the use of antivirals and antibiotics was higher in Asian studies compared to the US, Latin American, and European studies. A significant decline in the use of most therapeutics along with adverse outcomes of COVID-19 in pregnant women was observed. CONCLUSIONS: Geographical differences in therapeutic practice of COVID-19 were observed with differential rates of maternal and clinical outcomes. Minimizing the use of some therapeutics particularly antibiotics, antivirals, oxygen therapy, immunosuppressants, and hydroxychloroquine by risk stratification and careful consideration may further improve maternal and clinical outcomes.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Antiviral Agents/therapeutic use , COVID-19 Drug Treatment , COVID-19/therapy , Hydroxychloroquine/therapeutic use , Pregnancy Complications, Infectious/drug therapy , Pregnancy Complications, Infectious/epidemiology , Respiration, Artificial , SARS-CoV-2 , Adult , Asia/epidemiology , COVID-19/epidemiology , Cesarean Section , Europe/epidemiology , Female , Humans , Immunization, Passive , Infant, Newborn , Latin America/epidemiology , Length of Stay , Pregnancy , Pregnancy Complications, Infectious/virology , Pregnancy Outcome , Premature Birth , Treatment Outcome , United States/epidemiology , Young Adult , COVID-19 Serotherapy
3.
Reproduction ; 161(5): 581-591, 2021 04 20.
Article in English | MEDLINE | ID: mdl-33764899

ABSTRACT

Humanin (HN) is a short peptide involved in many biological processes such as apoptosis, cell survival, inflammatory response, and reaction to stressors like oxidative stress, between others. In the ovary, a correct balance between pro- and anti-apoptotic factors is crucial for folliculogenesis. In the follicular atresia, survival or death of granulosa cells is a critical process. The goal of this study was to evaluate the action of HN on granulosa cell fate. To explore endogenous HN function in the ovary, we used a recombinant baculovirus (BV) encoding a short-hairpin RNA targeted to silence HN (shHN). HN downregulation modified ovarian histoarchitecture and increased apoptosis of granulosa cells. HN was also detected in a granulosa tumor cell line (KGN). Transduction of KGN cells with BV-shHN resulted in HN downregulation and increased apoptosis. On the other hand, treatment of KGN cells with exogenous HN increased cell viability and decreased apoptosis. In summary, these findings indicate that HN is a cytoprotective factor in granulosa cells of antral follicles, suggesting that this peptide would be involved in the regulation of folliculogenesis. Also, this peptide is a cytoprotective factor in KGN cells, and therefore, it could be involved in granulosa tumor cell behavior.


Subject(s)
Cytoprotection , Granulosa Cell Tumor/pathology , Granulosa Cells/cytology , Intracellular Signaling Peptides and Proteins/metabolism , Ovarian Follicle/cytology , Ovary/cytology , Peptide Fragments/metabolism , Animals , Female , Granulosa Cell Tumor/metabolism , Intracellular Signaling Peptides and Proteins/antagonists & inhibitors , Intracellular Signaling Peptides and Proteins/genetics , Ovarian Follicle/metabolism , Ovary/metabolism , Oxidative Stress , Peptide Fragments/antagonists & inhibitors , Peptide Fragments/genetics , RNA, Small Interfering/genetics , Rats , Rats, Wistar
4.
Biol Reprod ; 104(5): 1058-1070, 2021 05 07.
Article in English | MEDLINE | ID: mdl-33524104

ABSTRACT

Oocytes are highly radiosensitive, so agents that prevent radiation-induced ovarian follicle destruction are important fertility preservation strategies. A previous study in rhesus macaques demonstrated that ovarian treatment with antiapoptotic agents, sphingosine-1-phosphate (S1P) and FTY720, its long-acting mimetic, preserved follicles following a single dose of 15 Gy X-ray radiation, and live offspring were obtained from FTY720-treated animals. However, it is unknown whether these antiapoptotic agents also protected the ovarian stroma from late effects of radiation, including vascular damage and fibrosis. Using ovarian histological sections from this study, we evaluated the vasculature and extracellular matrix in the following cohorts: vehicle + sham irradiation, vehicle + irradiation (OXI), S1P + irradiation (S1P), and FTY720 + irradiation (FTY720). One ovary from each animal was harvested prior to radiation whereas the contralateral ovary was harvested 10 months post-treatment. We assessed vasculature by immunohistochemistry with a PECAM1 antibody, hyaluronan by a hyaluronan binding protein assay, and collagen by picrosirius red and Masson's trichrome staining. Disorganized vessels were observed in the medulla in the OXI and S1P cohorts relative to the sham, but the vasculature in the FTY720 cohort appeared intact, which may partially explain fertoprotection. There were no differences in the hyaluronan matrix among the cohorts, but there was thickening of the tunica albuginea and fibrosis in the OXI cohort relative to the sham, which was not mitigated by either S1P or FTY720 treatment. Thus, the fertoprotective properties of S1P and FTY720 may be limited given their inability to protect the ovarian stroma against the late effects of radiation-induced fibrosis.


Subject(s)
Fibrosis/drug therapy , Fingolimod Hydrochloride/pharmacology , Immunosuppressive Agents/pharmacology , Lysophospholipids/pharmacology , Ovarian Diseases/drug therapy , Sphingosine 1 Phosphate Receptor Modulators/pharmacology , Sphingosine/analogs & derivatives , Animals , Female , Fibrosis/etiology , Macaca mulatta , Ovarian Diseases/etiology , Sphingosine/pharmacology
5.
Aging Cell ; 19(11): e13259, 2020 11.
Article in English | MEDLINE | ID: mdl-33079460

ABSTRACT

Fibrosis is a hallmark of aging tissues which often leads to altered architecture and function. The ovary is the first organ to show overt signs of aging, including increased fibrosis in the ovarian stroma. How this fibrosis affects ovarian biomechanics and the underlying mechanisms are unknown. Using instrumental indentation, we demonstrated a quantitative increase in ovarian stiffness, as evidenced by an increase in Young's modulus, when comparing ovaries from reproductively young (6-12 weeks) and old (14-17 months) mice. This ovarian stiffness was dependent on collagen because ex vivo enzyme-mediated collagen depletion in ovaries from reproductively old mice restored their collagen content and biomechanical properties to those of young controls. In addition to collagen, we also investigated the role of hyaluronan (HA) in regulating ovarian stiffness. HA is an extracellular matrix glycosaminoglycan that maintains tissue homeostasis, and its loss can change the biomechanical properties of tissues. The total HA content in the ovarian stroma decreased with age, and this was associated with increased hyaluronidase (Hyal1) and decreased hyaluronan synthase (Has3) expression. These gene expression differences were not accompanied by changes in ovarian HA molecular mass distribution. Furthermore, ovaries from mice deficient in HAS3 were stiffer compared to age-matched WT mice. Our results demonstrate that the ovary becomes stiffer with age and that both collagen and HA matrices are contributing mechanisms regulating ovarian biomechanics. Importantly, the age-associated increase in collagen and decrease in HA are conserved in the human ovary and may impact follicle development and oocyte quality.


Subject(s)
Collagen/metabolism , Extracellular Matrix/metabolism , Hyaluronan Synthases/metabolism , Ovary/physiopathology , Adult , Aging , Animals , Female , Humans , Mice
6.
Biol Reprod ; 99(4): 673-677, 2018 10 01.
Article in English | MEDLINE | ID: mdl-29688318

ABSTRACT

Immunohistochemistry (IHC) is a robust scientific tool whereby cellular components are visualized within a tissue, and this method has been and continues to be a mainstay for many reproductive biologists. IHC is highly informative if performed and interpreted correctly, but studies have shown that the general use and reporting of appropriate controls in IHC experiments is low. This omission of the scientific method can result in data that lack rigor and reproducibility. In this editorial, we highlight key concepts in IHC controls and describe an opportunity for our field to partner with the Histochemical Society to adopt their IHC guidelines broadly as researchers, authors, ad hoc reviewers, editorial board members, and editors-in-chief. Such cross-professional society interactions will ensure that we produce the highest quality data as new technologies emerge that still rely upon the foundations of classic histological and immunohistochemical principles.


Subject(s)
Genitalia/metabolism , Immunohistochemistry/methods , Animals , Antibody Specificity , Female , Guidelines as Topic , Humans , Immunohistochemistry/standards , Male , Reproducibility of Results , Societies, Scientific
7.
J Clin Immunol ; 33(7): 1223-39, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23888327

ABSTRACT

PURPOSE & METHODS: The immunopathogenic mechanisms responsible for debilitating neurodegenerative and oncologic diseases associated with human T-cell leukemia virus type 1 (HTLV-1) are not fully understood. Quality of cytotoxic T lymphocytes (CTLs) is being increasingly associated with the outcome of persistent HTLV-1 infection. In this respect, a patient cohort (from HTLV-1 endemic region) consisting of seronegative controls (controls), asymptomatic carriers (ACs), and patients with adult T-cell leukemia (ATL) or HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) was analyzed for CD8(+) T cells polyfunctionality in response to the viral antigen Tax. RESULTS: Compared to ACs, ATL and HAM/TSP patients had lower frequency and polyfunctionality of CTLs in response to Tax suggesting dysfunction of CD8(+) T cells in these individuals. As an underlying mechanism, programmed death-1 (PD-1) receptor was found to be highly unregulated in Tax-responsive as well as total CD8(+) T cells from ATL and HAM/TSP but not from ACs and directly correlated with the lack of polyfunctionality in these individuals. Further, PD-1 expression showed a direct whereas MIP-1α expression had an indirect correlation with the proviral load providing new insights about the immunopathogenesis of HTLV-associated diseases. Additionally, we identified key cytokine signatures defining the immune activation status of clinical samples by the luminex assay. CONCLUSIONS: Collectively, our findings suggest that reconstitution of fully functional CTLs, stimulation of MIP-1α expression, and/or blockade of the PD-1 pathway are potential approaches for immunotherapy / therapeutic vaccine against HTLV-mediated diseases.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , Human T-lymphotropic virus 1/immunology , Leukemia-Lymphoma, Adult T-Cell/immunology , Paraparesis, Tropical Spastic/immunology , Programmed Cell Death 1 Receptor/metabolism , Adolescent , Adult , Aged , Asymptomatic Diseases , CD8-Positive T-Lymphocytes/virology , Chemokine CCL3/genetics , Chemokine CCL3/metabolism , Cytokines/genetics , Cytokines/metabolism , Cytotoxicity, Immunologic , Female , Gene Expression Regulation , Gene Products, tax/immunology , Human T-lymphotropic virus 1/growth & development , Humans , Lymphocyte Activation , Lymphocyte Count , Middle Aged , Programmed Cell Death 1 Receptor/genetics , Transcriptome , Viral Load , Young Adult
8.
AIDS Res Hum Retroviruses ; 29(9): 1273-85, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23750452

ABSTRACT

The immunopathogenic mechanisms underlying human T cell leukemia virus type 1 (HTLV-1)-mediated diseases such as adult T cell leukemia (ATL) and HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) are not clearly understood. As critical effectors of antiviral immune response, dendritic cells (DCs) are implicated to play an important role in determining the outcome of HTLV-1 infection. However, a complete understanding of their role in any disease pathogenesis requires extensive assessment of the phenotypic and functional state of DCs. To enable this, we developed a polychromatic antibody cocktail comprising key phenotypic and functional markers of DCs and applied it in a patient cohort from the HTLV-1 endemic region, Jamaica, consisted of seronegative controls, asymptomatic carriers (ACs), ATL, and HAM/TSP patients. This ex vivo analyses included two major subsets of blood DCs, myeloid and plasmacytoid (mDCs and pDCs, respectively). The comparative analyses of results demonstrated a decreased pDC frequency in both ATL and HAM/TSP patients as compared to ACs and seronegative controls. Similarly, CD86 expression on both mDCs and pDCs was significantly higher in HAM/TSP (but not ATL) patients compared to ACs. Interestingly, HLA-DR expression was significantly lower on pDCs of patients as compared to carriers; however, for mDCs, only the HAM/TSP group had significantly lower expression of HLA-DR. Unlike HAM/TSP individuals, ATL individuals had higher HLA-ABC expression on mDCs compared to ACs. Finally, both mDCs and pDCs of HAM/TSP patients had significantly higher expression of the programmed death ligand 1 (PD-L1) compared to ACs. Overall, this study suggests that DCs exhibit a differential phenotypic and functional profile between patients (ATL and HAM/TSP) and carriers of HTLV-1 and could provide an important tool for understanding HTLV-1 immunopathogenesis during infection and disease.


Subject(s)
Carrier State/virology , Cell Adhesion/genetics , Dendritic Cells/immunology , Human T-lymphotropic virus 1/immunology , Paraparesis, Tropical Spastic/genetics , Adult , Antibodies, Viral , B7-2 Antigen/immunology , B7-2 Antigen/metabolism , B7-H1 Antigen/immunology , B7-H1 Antigen/metabolism , Biomarkers , Cohort Studies , Female , Fluorescent Antibody Technique , HLA-A Antigens/immunology , HLA-A Antigens/metabolism , HLA-B Antigens/immunology , HLA-B Antigens/metabolism , HLA-C Antigens/immunology , HLA-C Antigens/metabolism , HLA-DR Antigens/immunology , HLA-DR Antigens/metabolism , Human T-lymphotropic virus 1/genetics , Humans , Male , Middle Aged , Paraparesis, Tropical Spastic/immunology , Paraparesis, Tropical Spastic/virology
9.
J Clin Cell Immunol ; 2(1)2011 Jan 07.
Article in English | MEDLINE | ID: mdl-21866203

ABSTRACT

Liver disease caused by HIV-1/HCV co-infection is characterized by the inflammation and cell-death. The co-existence of these two chronic viral infections also alters the cytokine production in vivo. The ability to visualize changes in cytokine networks with the onset and progression of disease or treatment is critical to advance our understanding of the immune response to pathogens. The recent Luminex® technology has revolutionized the simultaneous detection and quantitation of several cytokines and chemokines in clinical samples that are generally available in small quantities. We have applied this technology to analyze the plasma samples from patients who have either HIV-1 or HCV mono-infection or HIV-1/HCV co-infection and monitored the presence of 23 cytokines and chemokines. Of these, 8 (IFN-α2, IL-2, IL-3, IL-6, IL-8, IL-12p70, IL-15 and RANTES) cytokines were expressed at higher levels in the co-infected individuals. Interestingly, in case of HIV-1 mono-infected individuals, the levels of the proinflammatory cytokines IFN-γ and TNF-α were increased. Standard correlation clustering of the normalized data demonstrated unique plasma cytokine signatures for HIV-1/HCV co-infected individuals. These signatures were characterized not only by an up regulation of the aforementioned antiviral mediators but also by a marked down regulation in the chemokines Eotaxin and MIP-1α when compared to mono-infected individuals. Luminex®- based analyses have proven to be a powerful tool for therapeutic immunomonitoring, but may have an even greater impact in the discovery of the underlying immune response at all phases of infection. The study presented herein has potential to offer insight into the underlying mechanisms of immunopathogenesis of HIV-1/HCV co-infection.

10.
J Immunol ; 184(10): 5553-61, 2010 May 15.
Article in English | MEDLINE | ID: mdl-20382884

ABSTRACT

Human T cell leukemia virus type 1 (HTLV-1) is associated with two immunologically distinct diseases: HTLV-1-associated myelopathy/tropical spastic paraparesis and adult T cell leukemia. The genesis of these diseases is believed to be associated with the route (mucosa versus blood) and mode (cell-free versus cell-associated) of primary infection as well as the modulation of dendritic cell (DC) functions. To explore the role of DCs during early HTLV-1 infection in vivo, we used a chimeric HTLV-1 with a replaced envelope gene from Moloney murine leukemia virus to allow HTLV-1 to fuse with murine cells, which are generally not susceptible to infection with human retroviruses. We also used a CD11c-diphtheria toxin receptor transgenic mouse model system that permits conditional transient depletion of CD11c(+) DCs. We infected these transgenic mice with HTLV-1 using both cell-free and cell-associated infection routes in the absence and presence of DCs. The ablation of DCs led to an enhanced susceptibility to infection with cell-free but not cell-associated HTLV-1 in both CD4 and non-CD4 fractions, as measured by the proviral load. Infection with cell-free virus in the absence of DCs was also found to have increased levels of Tax mRNA in the non-CD4 fraction. Moreover, depletion of DCs significantly dampened the cellular immune response (IFN-gamma(+)CD8(+) T cells) against both cell-free and cell-associated virus. These results uniquely differentiate the involvement of DCs in early cell-free versus late cell-associated infection of HTLV-1 and highlight a significant aspect of viral immunopathogenesis related to the progression of adult T cell leukemia and HTLV-1-associated myelopathy/tropical spastic paraparesis after the initial infection.


Subject(s)
CD11c Antigen/genetics , Dendritic Cells/immunology , Human T-lymphotropic virus 1/immunology , Intercellular Signaling Peptides and Proteins/genetics , Leukapheresis , Paraparesis, Tropical Spastic/immunology , Animals , Cell Death/genetics , Cell Death/immunology , Cell Line , Cell-Free System/immunology , Cell-Free System/pathology , Cell-Free System/virology , Dendritic Cells/pathology , Diphtheria Toxin/genetics , Diphtheria Toxin/metabolism , Disease Susceptibility/immunology , Disease Susceptibility/virology , Heparin-binding EGF-like Growth Factor , Human T-lymphotropic virus 1/genetics , Humans , Leukapheresis/methods , Mice , Mice, Inbred C57BL , Mice, Transgenic , Paraparesis, Tropical Spastic/metabolism , Paraparesis, Tropical Spastic/virology
11.
J Virol ; 83(21): 10908-21, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19692463

ABSTRACT

Despite the susceptibility of dendritic cells (DCs) to human T-cell lymphotropic virus type 1 (HTLV-1) infection and the defined role of these cells in disease pathogenesis, the mechanisms of viral binding to DCs have not been fully delineated. Recently, a glucose transporter, GLUT-1, heparan sulfate proteoglycans (HSPGs), and neuropilin-1 (NRP-1) were demonstrated to facilitate HTLV-1 entry into T cells. DCs express their own array of antigen receptors, the most important being the DC-specific intercellular adhesion molecule-3 (ICAM-3)-grabbing nonintegrin (DC-SIGN) with respect to retrovirus binding. Consequently, the role of DC-SIGN and other HTLV-1 attachment factors was analyzed in viral binding, transmission, and productive infection using monocyte-derived DCs (MDDCs), blood myeloid DCs, and B-cell lines expressing DC-SIGN. The relative expression of DC-SIGN, GLUT-1, HSPGs, and NRP-1 first was examined on both DCs and B-cell lines. Although the inhibition of these molecules reduced viral binding, HTLV-1 transmission from DCs to T cells was mediated primarily by DC-SIGN. DC-SIGN also was shown to play a role in the infection of MDDCs as well as model B-cell lines. The HTLV-1 infection of MDDCs also was achieved in blood myeloid DCs following the enhancement of virus-induced interleukin-4 production and subsequent DC-SIGN expression in this cell population. This study represents the first comprehensive analysis of potential HTLV-1 receptors on DCs and strongly suggests that DC-SIGN plays a critical role in HTLV-1 binding, transmission, and infection, thereby providing an attractive target for the development of antiretroviral therapeutics and microbicides.


Subject(s)
Cell Adhesion Molecules/immunology , Dendritic Cells , Human T-lymphotropic virus 1 , Lectins, C-Type/immunology , Receptors, Cell Surface/immunology , Animals , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/virology , Cell Adhesion Molecules/genetics , Cells, Cultured , Dendritic Cells/metabolism , Dendritic Cells/virology , Gene Products, env/genetics , Gene Products, env/metabolism , Glucose Transporter Type 1/genetics , Glucose Transporter Type 1/metabolism , Heparan Sulfate Proteoglycans/metabolism , Human T-lymphotropic virus 1/immunology , Human T-lymphotropic virus 1/pathogenicity , Humans , Interleukin-4/immunology , Lectins, C-Type/genetics , Neuropilin-1/genetics , Neuropilin-1/metabolism , RNA Interference , Receptors, Cell Surface/genetics , Retroviridae Proteins, Oncogenic/genetics , Retroviridae Proteins, Oncogenic/metabolism , Virus Attachment , Virus Internalization , Virus Replication
12.
J Leukoc Biol ; 86(5): 1205-16, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19656902

ABSTRACT

HTLV-1 is the etiologic agent of a debilitating neurologic disorder, HAM/TSP. This disease features a robust immune response including the oligoclonal expansion of CD8+ CTLs specific for the viral oncoprotein Tax. The key pathogenic process resulting in the proliferation of CTLs and the presentation of Tax peptide remains uncharacterized. We have investigated the role of APCs, particularly DCs, in priming of the anti-Tax CTL response under in vitro and in vivo conditions. We investigated two routes (direct vs. indirect) of Tax presentation using live virus, infected primary CD4+/CD25+ T cells, and the CD4+ T cell line (C8166, a HTLV-1-mutated line that only expresses Tax). Our results indicated that DCs are capable of priming a pronounced Tax-specific CTL response in cell cultures consisting of naïve PBLs as well as in HLA-A*0201 transgenic mice (line HHD II). DCs were able to direct the presentation of Tax successfully through infected T cells, live virus, and cell-free Tax. These observations were comparable with those made with a known stimulant of DC maturation, a combination of CD40L and IFN-gamma. Our studies clearly establish a role for this important immune cell component in HTLV-1 immuno/neuropathogenesis and suggest that modulation of DC functions could be an important tool for therapeutic interventions.


Subject(s)
Deltaretrovirus Infections/physiopathology , Dendritic Cells/immunology , Gene Products, tax/biosynthesis , Human T-lymphotropic virus 1/physiology , Nervous System Diseases/virology , Animals , Antigens, CD/immunology , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/virology , CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/virology , Cell Line , Deltaretrovirus Infections/immunology , Gene Products, tax/immunology , Human T-lymphotropic virus 1/immunology , Humans , Interferon-gamma/analysis , Interleukin-2 Receptor alpha Subunit/immunology , Mice , Nervous System Diseases/immunology , Nervous System Diseases/physiopathology , T-Lymphocytes/immunology , T-Lymphocytes/virology , T-Lymphocytes, Cytotoxic/immunology , T-Lymphocytes, Cytotoxic/virology
13.
Front Biosci ; 12: 4315-35, 2007 May 01.
Article in English | MEDLINE | ID: mdl-17485377

ABSTRACT

Dendritic cells are the most potent antigen presenting cells and have long been recognized as key regulators of the immune system, linking both stimulatory and inhibitory components of normal immunity. While DCs are fully characterized with respect to primary and secondary immune responses, their unique role in coordinating central and peripheral tolerance is just emerging. It is increasingly evident that the failure of DCs ability to maintain tolerance can lead to autoimmune and/or inflammatory diseases. However, existing literature highlighting participation of DCs in several autoimmune phenomena is scattered and remains underappreciated. This review is a comprehensive account of current knowledge characterizing the role of DCs in various autoimmune diseases including psoriasis, rheumatoid arthritis, systemic lupus erythematosus, Sjogren's syndrome, and diabetes. Additionally, it provides a rare description of DCs participation in various neuroinflammatory disorders including multiple sclerosis, HAM/TSP, Alzheimer disease and prion-associated diseases. Finally, a detailed description of the possible mechanisms of DC involvement in regulating immune response towards self versus non-self is discussed. Overall, the goal of this review is to establish DCs in the interface of tolerance and autoimmunity and generate a global interest in this field in order to exploit DC potential for the therapy of inflammatory diseases.


Subject(s)
Autoimmune Diseases/immunology , Dendritic Cells/immunology , Inflammation/immunology , Nervous System Diseases/immunology , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...